RAP2B and colorectal carcinoma: Beyond its established role in inflammation-driven tumorigenesis discussed in this context, Rap2B’s intrinsic oncogenic functions may synergize with its involvement in intestinal epithelial cell IEC injury, thereby exacerbating CRC progression.